Cargando…
Passive Immunization with Anti-Pertussis Toxin Humanized Monoclonal Antibody Mitigates Clinical Signs of Pertussis Infection in Newborn Baboons
BACKGROUND: Pertussis is a significant mortality risk in the developing world, killing up to 200,000 infants annually. Maternal vaccination as a strategy to protect newborns has shown some success, but is unlikely to capture all eligible mothers. Hu1B7 is a monoclonal antibody (mAb) that potently ne...
Autores principales: | Maynard, Jennifer, Nguyen, Annalee, Wolf, Roman, Papin, James, Connelly, Sheila, Kaleko, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631686/ http://dx.doi.org/10.1093/ofid/ofx162.009 |
Ejemplares similares
-
Neutralization of pertussis toxin by a single antibody prevents clinical pertussis in neonatal baboons
por: Nguyen, Annalee W., et al.
Publicado: (2020) -
Prior exposure to Bordetella species as an exclusion criterion in the baboon model of pertussis
por: NGUYEN, Annalee W., et al.
Publicado: (2016) -
Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons Against Bordetella pertussis Disease and Infection
por: Locht, Camille, et al.
Publicado: (2017) -
Association of Pertussis Toxin with Severe Pertussis Disease
por: Scanlon, Karen, et al.
Publicado: (2019) -
Secretion of Pertussis Toxin from Bordetella pertussis
por: Burns, Drusilla L.
Publicado: (2021)